AliveCor's six-lead consumer ECG device gains FDA clearance

May 27, 2019
Digital Transformation More...
by Nardev Ramanathan
Very important

The traditional 12-lead ECG machine (gold standard for medical use) is unfortunately bulky, with a dozen wires and needing conductive gels to measure the heart's electrical signal. Apple's smartwatch looked to combat this inconvenience by offering a single-lead ECG device in an everyday form factor. However, the device still suffers from a high false positive rate. AliveCor's latest offering features a six-lead ECG device, striking a balance between a 12-lead and a single-lead ECG device. The device allows users to capture ECG data from knees or ankles, unlike a smartwatch. Real-world data is still necessary to validate AliveCor's claim for clinical use, but AliveCor's focus on more biological data points is a step in the right direction. 

For the original news article, click here .

Further Reading

Respiration monitoring company moves to less crowded market, breathes sigh of relief

News Commentary | February 15, 2019

Spire, a respiration monitoring company that has focused on wearables for stress management, has rebranded itself to Spire Health in order to focus on the healthcare market. As noted previously, the stress management space is crowded with wearables that combine fitness tracking and sleep monitoring ... Not part of subscription

Royal Philips launches new positional sleep apnea device

News Commentary | September 26, 2019

The new sleep apnea product targets positional sleep apnea, which is better addressed through changing sleeping position throughout the night than the traditional CPAP mask.  This new product launch is part of a growing interest in digital health for the monitoring and management of sleep, ranging ... To read more, click here.

Fitbit launches atrial fibrillation study

News Commentary | May 14, 2020

Fitbit's atrial fibrillation (AFib) study will allow the company to compete with Apple Watch claims. While Apple has the advantage of having received FDA clearance for its AFib‑detecting algorithm, the product has frustrated both the medical community and users with high rates of false positives. To... To read more, click here.